Source: Eur Respir J, 57 (3) 2004562; 10.1183/13993003.04562-2020
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Samy Suissa, Deborah Assayag. Mortality benefit with antifibrotics in idiopathic pulmonary fibrosis: real world evidence or bias?. Eur Respir J, 57 (3) 2004562; 10.1183/13993003.04562-2020

Member's Comments

emily faye - 14.08.2023 08:24
I have been suffering from Herpes for the past 1 years and 8 months, and ever since then i have been taking series of treatment but there was no improvement until i came across testimonies of Dr. Silver on how he has been curing different people from different diseases all over the world, then i contacted him as well. After our conversation he sent me the medicine which i took according .to his instructions. When i was done taking the herbal medicine i went for a medical checkup and to my greatest surprise i was cured from Herpes. My heart is so filled with joy. If you are suffering from Herpes or any other disease you can contact Dr. Silver today on this Email address: drsilverhealingtemple@gmail.com or whatsapp +2348120513902

emily faye - 14.08.2023 08:24
I have been suffering from Herpes for the past 1 years and 8 months, and ever since then i have been taking series of treatment but there was no improvement until i came across testimonies of Dr. Silver on how he has been curing different people from different diseases all over the world, then i contacted him as well. After our conversation he sent me the medicine which i took according .to his instructions. When i was done taking the herbal medicine i went for a medical checkup and to my greatest surprise i was cured from Herpes. My heart is so filled with joy. If you are suffering from Herpes or any other disease you can contact Dr. Silver today on this Email address: drsilverhealingtemple@gmail.com or whatsapp +2348120513902

becky lisa - 11.06.2023 08:07
I want to quickly recommend Dr Akhigbe to you all out here. This Doc got medicine that helps in losing weight, obesity, burning fat belly, and also has special meds for Infertility in men/women, penis enlargement, ALS, Hepatitis ,erectile dysfunction/weak erection, HSV, low sperm count, pregnancy meds and many more. You can contact Dr Akhigbe on whatsapp +2349021374574. Or email him at Drakhigbeherbalhome5@gmail.com



liberty jasy - 04.07.2022 04:29
My husband had ALS, first symptom was weakness in his fingers, one day, we had a dream life with early retirement and then, when we went to find out about the weakness, our whole world almost changed. There are so many things that can be said about the suffering and frustration of people with ALS, we look back now and realize in many ways how lucky we were to found Dr. Timothy herbal cure that was able to get rid of my husband ALS disease totally, we had time to enjoy life and above all we all had time to also share this great testimony , many people lose loved ones without closure. I can’t imagine going thru all that you or your family had to live with daily, do not hesitate to contact https://5dc41d5b6d60d.site123.me or email goodhealthherbalfoundation@yahoo.com for ALS cure.

Teresa Lawrence - 21.12.2021 10:28
It’s difficult not knowing what the next day will bring. To anyone who’s just been diagnosed with IPF, or another long-term lung condition, I’d say live life to the full and take all the help you can get. It can be difficult to talk to your family and friends about what you’re going through, but it’s important to make sure they understand what’s happening and how you’re feeling. I was cured naturally with the use of Dr Gomez Sims RSO Cannabis Oil, within a period of 3 weeks, I was recovering, It’s also crucial to learn as much as you can about your diagnosis. Seek options. Find out about what’s out there that could help. Contact Dr Odia via email:( drodiaherbalistcenter@gmail.com ) or ( WhatsApp +17278553511 ) or visit www.facebook.com/DrOdiathenaturopathic/

Related content which might interest you: Mortality outcomes in patients with idiopathic pulmonary fibrosis treated with antifibrotics: a real world study Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021 The increasing mortality of idiopathic pulmonary fibrosis: fact or fallacy? Source: Eur Respir J, 51 (1) 1702420; 10.1183/13993003.02420-2017 Year: 2018 Early COVID-19 lockdown in Greece and idiopathic pulmonary fibrosis: a beneficial “impact” beyond any expectation Source: Eur Respir J, 57 (3) 2003111; 10.1183/13993003.03111-2020 Year: 2021 Antithrombotics in idiopathic pulmonary fibrosis patients with concomitant antifibrotic therapy: a single centre real world experience Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 Historical eye on idiopathic pulmonary fibrosis: redefining the mortality scenario. Source: Virtual Congress 2020 – New clinical insights into idiopathic pulmonary fibrosis Year: 2020 Does timeliness of diagnosis influence survival and treatment response in idiopathic pulmonary fibrosis?  Real- world results from the EMPIRE registry. Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside Year: 2017 Efficacy of switching antifibrotic therapy in idiopathic pulmonary fibrosis: real life data Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019 Real-life experience with pirfenidon in idiopathic pulmonary fibrosis: Does early treatment start predict better therapy adherence? Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Healthy survivor bias in patients with idiopathic pulmonary fibrosis in clinical registries. Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021 Insights into idiopathic pulmonary fibrosis in the real world Source: Eur Respir J 2015; 46: 16-18 Year: 2015 Late Breaking Abstract - Survival and course of lung function in patients with idiopathic pulmonary fibrosis with or without antifibrotic treatment: long-term results of the INSIGHTS-IPF registry Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019 Idiopathic pulmonary fibrosis: time for greater expectations? Source: Eur Respir J, 52 (2) 1801312; 10.1183/13993003.01312-2018 Year: 2018 Idiopathic pulmonary fibrosis mortality in the United States: is there any evidence of occupational risk? Source: Eur Respir J 2005; 26: Suppl. 49, 702s Year: 2005 Assessing the effectiveness of pirfenidone in changing the natural course of idiopathic pulmonary fibrosis: the data from European IPF Registry (eurIPFreg). Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 Emerging potential treatments: new hope for idiopathic pulmonary fibrosis patients? Source: Eur Respir Rev 2011; 20: 201-207 Year: 2011 A global registry for idiopathic pulmonary fibrosis: the time is now Source: Eur Respir J 2014; 44: 273-276 Year: 2014 The value of the surprise question to predict mortality in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis? Year: 2020 Long-term outcomes of antifibrotic treatments in patients with idiopathic pulmonary fibrosis: Real-world experience Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 Pirfenidone treatment in idiopathic pulmonary fibrosis: too much of a great expectation Source: Eur Respir J 2012; 40: 794-795 Year: 2012 Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential Source: Eur Respir Rev, 26 (145) 170071; 10.1183/16000617.0071-2017 Year: 2017